Suppr超能文献

与可切除胰腺导管腺癌患者的诊断、临床病理标准和总生存期相关的 microRNA 分子谱。

MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma.

机构信息

West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Alexandra Parade, Glasgow, G31 2ER, United Kingdom.

出版信息

Clin Cancer Res. 2012 Jan 15;18(2):534-45. doi: 10.1158/1078-0432.CCR-11-0679. Epub 2011 Nov 23.

Abstract

PURPOSE

MicroRNAs (miRNA) have potential as diagnostic and prognostic biomarkers and as therapeutic targets in cancer. We sought to establish the relationship between miRNA expression and clinicopathologic parameters, including prognosis, in pancreatic ductal adenocarcinoma (PDAC).

EXPERIMENTAL DESIGN

Global miRNA microarray expression profiling of prospectively collected fresh-frozen PDAC tissue was done on an initial test cohort of 48 patients, who had undergone pancreaticoduodenectomy between 2003 and 2008 at a single institution. We evaluated association with tumor stage, lymph node status, and site of recurrence, in addition to overall survival, using Cox regression multivariate analysis. Validation of selected potentially prognostic miRNAs was done in a separate cohort of 24 patients.

RESULTS

miRNA profiling identified expression signatures associated with PDAC, lymph node involvement, high tumor grade, and 20 miRNAs were associated with overall survival. In the initial cohort of 48 PDAC patients, high expression of miR-21 (HR = 3.22, 95% CI: 1.21-8.58) and reduced expression of miR-34a (HR = 0.15, 95% CI: 0.06-0.37) and miR-30d (HR = 0.30, 95% CI: 0.12-0.79) were associated with poor overall survival following resection independent of clinical covariates. In a further validation set of 24 patients, miR-21 and miR-34a expression again significantly correlated with overall survival (P = 0.031 and P = 0.001).

CONCLUSION

Expression patterns of miRNAs are significantly altered in PDAC. Aberrant expression of a number of miRNAs was independently associated with reduced survival, including overexpression of miR-21 and underexpression of miR-34a.

SUMMARY

miRNA expression profiles for resected PDAC were examined to identify potentially prognostic miRNAs. miRNA microarray analysis identified statistically unique profiles, which could discriminate PDAC from paired nonmalignant pancreatic tissues as well as molecular signatures that differ according to pathologic features. miRNA expression profiles correlated with overall survival of PDAC following resection, indicating that miRNAs provide prognostic utility.

摘要

目的

microRNAs(miRNA)在癌症中具有作为诊断和预后生物标志物以及治疗靶点的潜力。我们试图确定 miRNA 表达与临床病理参数之间的关系,包括在胰腺导管腺癌(PDAC)中的预后。

实验设计

对 2003 年至 2008 年间在一家机构接受胰十二指肠切除术的 48 例患者的前瞻性收集的新鲜冷冻 PDAC 组织进行了全局 miRNA 微阵列表达谱分析。我们使用 Cox 回归多变量分析评估了与肿瘤分期、淋巴结状态和复发部位以及总生存率的相关性。在另一个单独的 24 例患者队列中验证了选定的潜在预后 miRNA。

结果

miRNA 谱分析确定了与 PDAC、淋巴结受累、高肿瘤分级相关的表达特征,并且 20 个 miRNA 与总生存率相关。在 48 例 PDAC 患者的初始队列中,miR-21 的高表达(HR=3.22,95%CI:1.21-8.58)和 miR-34a(HR=0.15,95%CI:0.06-0.37)和 miR-30d(HR=0.30,95%CI:0.12-0.79)的低表达与切除后总体生存率降低独立于临床协变量相关。在进一步的验证队列 24 例患者中,miR-21 和 miR-34a 的表达再次与总生存率显著相关(P=0.031 和 P=0.001)。

结论

miRNA 在 PDAC 中的表达模式发生了显著改变。一些 miRNA 的异常表达与生存率降低独立相关,包括 miR-21 的过表达和 miR-34a 的低表达。

总结

检查了切除 PDAC 的 miRNA 表达谱,以鉴定潜在的预后 miRNA。miRNA 微阵列分析确定了具有统计学意义的独特谱,可以区分 PDAC 与配对的非恶性胰腺组织,以及根据病理特征而不同的分子特征。miRNA 表达谱与 PDAC 切除后的总生存率相关,表明 miRNA 提供了预后效用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验